Wordt geladen...
Alemtuzumab-induced elimination of HIV-1-infected immune cells
BACKGROUND: : Currently, there is no drug known that is able to eradicate either HIV or HIV-infected host cells. The effectiveness of all available treatments is based on the prevention of viral replication. We investigated whether the monoclonal, CD52 receptor-targeting antibody, alemtuzumab, which...
Bewaard in:
| Gepubliceerd in: | J Virus Erad |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Mediscript Ltd
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4946689/ https://ncbi.nlm.nih.gov/pubmed/27482429 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|